Close

Analyst Ratings for Ultragenyx Pharma (RARE) [Neutrals]

All Latest Ratings for RARE

RARE Rating Summary

RARE Price Target Summary

* Over Last 12-Mos
  |   Expand Research on RARE
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $88.00 (+81.8%) * Over Last 12-Mos
Rating Score: 7.4 / 10   Percentile Rank: 78%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/1/2022 Evercore ISI Liisa Bayko Downgrade In Line
(Outperform)		 60.00
(95.00)		 51.88
(48.41)		 -6.69% Details
12/7/2020 Wedbush
» Updated 2/17/2023		 Laura Chico Downgrade Neutral
(Outperform)		 47.00
(48.00)		 128.53
(48.41)		 -62.34% Details
Like RARE Ratings? Also take a look at RCKT, XFOR, MREO, NTLA

RARE Ratings News